Back to search results

E3 Hypertension Study for Blood Pressure Control

This study is testing two approaches to help people with uncontrolled high blood pressure (hypertension) better manage their condition. One approach, called the E3 Multidisciplinary Team, involves a remote pharmacist, social worker, and nurse working with you through a phone app to help with lifestyle changes and medication. The other approach, the E3 Self-Guided Hypertension Education Program, provides mailed educational materials on blood pressure monitoring, diet, and lifestyle. The goal is to see if these programs can help lower your systolic blood pressure (the top number in a blood pressure reading) over 6 months. You may be able to join if you are an African American or Latinx adult, 18 or older, with uncontrolled stage 2 hypertension, a smartphone, and an email, and are a patient at a Rush primary care clinic. The current recruitment status is unclear.

Study design
This interventional study plans to enroll 200 participants. It compares two different behavioral interventions for managing high blood pressure.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Your systolic blood pressure will be measured at 6 months to see the change.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06899750

E3 Hypertension - A Team-based, Multidisciplinary Model in Addressing Barriers to Hypertension Control

Recruiting
NAAges 18+InterventionalTreatment
Rush University Medical Center
~200 participants
Updated 2026-06-18 on ClinicalTrials.gov
What's tested:E3 Multidisciplinary TeamE3 Self-Guided Hypertension Education Program

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Systolic blood pressure change at 6 months
Measured over 6 months

Conditions

Hypertension

Explore related trials

Hypertension

Where it's being run

1 sites across 1 states
Illinois1

Study leadership

  • Kristen Pallok, MD · PRINCIPAL_INVESTIGATOR · Rush University Medical Center

Who to contact

Kristen Pallok, MD
[email protected]
13129426700
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Adults 18 years or older
African American and/or Latinx
Uncontrolled stage 2 hypertension, BP \>/= 140/90
Patient is following with Rush primary care provider in eligible Rush primary care clinics
Patient has a smart phone (Android or iOS)
Patient has an email

Exclusion

Organ transplant recipient
On dialysis
Patient is already participating in another remote hypertension monitoring program
Patient is not interested in participating in the program
Patient has already participated in the E3 Hypertension program or the E3 Diabetes program

What this trial measures

  • Systolic blood pressure change at 6 months6 months

    Percentage of participants with a decrease in systolic blood pressure of at least 10mmHg between pre and post clinic-based blood pressure measurements.